Clinical Trials

Study NamePISponsorDescriptionBegunStatus
STAR VT Dhanunjaya Lakkireddy, MD SJM VT ablation/ ICD/ meds vs ICD and meds only 5/29/2015 In follow-Up
MSP2017 Dhanunjaya Lakkireddy, MD Milestone Phase II drug study for SVT 6/18/2015 Enrolling
Tacticath Dhanunjaya Lakkireddy, MD SJM Post-approval study to evaluate safety of TactiCath 7/8/2015 In follow-Up
Score Loren Berenbom, MD SJM Evaluate acute and long-term performance of market released SJM products by analyzing product survival possibilities 10/9/2012 In follow-Up
Evolut R Trip Zorn, MD MDT New generation aortic valve for TAVR 12/12/2014 In Follow-Up
Reprise III Trip Zorn, MD BOS SCI LOTUS valve 3/12/2015 In follow-Up
Fame3 Peter Tadros, MD Stanford University To compare CABG procedure to the implant of multiple stents 4/20/2015 Enrolling
Ilumien Peter Tadros, MD SJM To evaluate the safety and effectiveness of two devices(OCT and IVUS)  In follow-Up
Cardiac Lead Assessment Study Dhanunjaya Lakkireddy, MD SJM Imaging study of specific SJM leads to check for malfunction Enrolling
reMarqable Dhanunjaya Lakkireddy, MD BSW Investigational ablation catheter study In Follow-Up
COMMENCE Trial Trip Zorn, MD Edwards Dry-packed investigational valve In Follow-Up
REVEAL AF  Rhea Pimentel, MD MDT Study of reveal ILR in patients w/o documented rhythm issues In Follow-Up
CoreValve Continued Access Trip Zorn, MD MDT Continued access study for extreme risk patients 03/2012 In Follow-up
ABSORB RCT Mark Wiley, MD AVD IDE study of a bio-resorbable coronary stent system vs XIENCE DES In Follow-up
Analyze-ST Raghuveer Dendi, MD SJM IDE study of ICD with ST change monitoring capability 03/2012 In Follow-Up
HEARTLIGHT Dhanunjaya Lakkireddy, MD Cardiofocus IDE study of endoscopic ablation system 03/2012 In Follow-up
COAPT Peter Tadros, MD AVD Mitraclip vs Standard Care Enrolling
Corevalve Expanded use Trip Zorn, MD MDT TAVI in high surgical risk patients 12/2012 In follow-Up
OAT Trial Dhanunjaya Lakkireddy, MD BSW Safety of oral anticoagulation therapy withdrawal after PVI in pts with AF and high risk factors for embolic events 12/2012 Enrolling
PPP /PSR/SLS Dhanunjaya Lakkireddy, MD MDT long-term following of FDA-Approved MDT Cardiac Rhythm Management devices 07/2009 Enrolling
Surescan Dhanunjaya Lakkireddy, MD MDT Post approval study of MRI-compatible ICD system 09/2011 In Follow-Up
SURTAVI Trip Zorn,MD MDT TAVI in intermediate surgical risk patients 12/2012 Enrolling
ALLSTAR Buddhadeb Dawn, MD Capricor Allogeneic Cardiosphere-derived stem cells in Anterior MI Enrolling
FMD Registry Kamal Gupta, MD FMDSA Registry of patients with FibromuscularDysplasia 11/2013 Enrolling
LEADLESS II Dhanunjaya Lakkireddy, MD SJM Leadless Pacemaker 6/19/2014 Enrolling
NAVIGATE X4 Martin Emert, MD BOS SCI Investigational Quadripolar Lead 9/1/2014 In Follow-Up
PARACHUTE Mark Wiley CardioKInetix Investigational LV device in pts w/CHF Enrolling
AMAZE Dhanunjaya Lakkireddy, MD Sentre HEART To demonstrate that the adjunctive percutaneous LAA ligation procedure does not result in an unacceptable risk of serious adverse events (SAEs) in persistent or longstanding persistent AF subjects for whom a catheter ablation procedure is planned 11/13/2015 Enrolling
RLX030A Ryan Ferrell, MD Novartis Use of serelaxin in acute heart failure patients 9/15/2015 In Follow-Up
TOBA II Kamal Gupta, MD Intact Vascular TACK device in patients with PAD 1/28/2016 Enrolling
QP Excels Dhanunjaya Lakkireddy, MD Biotronik Investigational Quadripolar Lead 3/10/2016 Enrolling
WRAP-IT Dhanunjaya Lakkireddy, MD Medtronic To compare the rate of major CIED infections through 12 months post-implant between the TYRX envelope group and the control group 3/10/2016 Enrolling
SALUS Trip Zorn, MD Direct Flow Medical Randomized trial between the Direct Flow Medical TAVR valve and the Medtronic TAVR valve 4/12/2016 Enrolling
Enticed AF Dhanunjaya Lakkireddy, MD ERF  To compare the rates of local and systemic bleeding in patients randomized to Edoxaban compared to patients randomized to continuous Warfarin in within 30 days of cardiac rhythm device implant with concomitant non-valvular AF 3/4/2016 Enrolling
AUGUSTUS Hockstad, MD Bristol-Myers Squibb To evaluate the safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and ACS or PCI 8/12/2016 Enrolling
cVAD Registry Peter Tadros, MD Abiomed Retrospective registry study of patients who received an Impella device 8/9/2016 Enrolling
Evolut R Low Risk Trip Zorn, MD Medtronic Evaluate the safety and effectiveness of the Medtronic TAVR System in patients with severe aortic stenosis at low risk for SAVR 8/24/2016 Enrolling
TAVR 2.0 Peter Tadros, MD Medtronic To evaluate the safety and efficacy of the Medtronic TAVR 2.0 system in SAS pts with high to extreme risk for SAVR 9/8/2016 Enrolling
Magnetic VT Dhanunjaya Lakkireddy, MD Stereotaxis Comparing outcomes of  Ischemic scar ventricular VT ablation with NiobeTM ES to manual approach 8/17/2016 Enrolling
Last modified: Oct 08, 2012